Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.
Julien and Kiersten Saunders have made a name for themselves as the regular rich couple, with a mission to inspire better conversations about money and help everyday folk tackle their finances, ...
We recently published an article titled Jim Cramer’s Lightning Rounds: 9 Stocks in Focus. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against ...
Investment in the global low-carbon energy transition grew 11% to reach $2.1tn in 2024, according to a report by BloombergNEF's Energy Transition Investment Trends 2025. Electrified transport, ...
Nisa Investment Advisors LLC grew its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 23.1% ...
Karen Chang — who has played a key role in the company's Canada-based battery gigafactory, Six project — will serve as interim CEO in the transition period. Cerruti will retain his role as chairman of ...
The Spire Inc. (NYSE: SR) board of directors declared a quarterly common stock dividend of $0.785 per share, payable April 2, ...
Tax season is officially underway, and it’s important to understand how your income might impact your tax bracket. Yahoo ...
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
The European Central Bank (ECB) announced on Thursday it was lowing the benchmark deposit rate to 2.75% as the eurozone economy continues to show weakness. The quarter-point cut was the fifth time the ...
Sarepta Therapeutics (NASDAQ:SRPT), a biotechnology company specializing in precision genetic medicines for rare diseases with a market capitalization of $11.2 billion, stands at a critical juncture ...
The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...